Core Viewpoint - China Bank's stock price has shown a significant increase this year, with a year-to-date rise of 11.24% and a recent uptick of 3.90% over the last five trading days [2] Group 1: Stock Performance - As of November 14, China Bank's stock price rose by 2.09% to 5.86 CNY per share, with a trading volume of 12.47 billion CNY and a turnover rate of 0.10% [1] - The stock has experienced a 9.74% increase over the past 20 days and a 5.21% increase over the past 60 days [2] Group 2: Financial Performance - For the period from January to September 2025, China Bank reported a net profit attributable to shareholders of 177.66 billion CNY, reflecting a year-on-year growth of 1.08% [2] - The bank's main business revenue composition includes personal financial services (39.47%), corporate financial services (36.29%), funding services (14.84%), investment banking and insurance (6.40%), and other businesses (3.00%) [2] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for China Bank reached 678,900, an increase of 10.32% from the previous period [2] - The top three circulating shareholders include China Securities Finance Corporation with 7.941 billion shares, unchanged from the previous period, and Hong Kong Central Clearing Limited with 888 million shares, which decreased by 762 million shares [3]

Group 1 - Nanshan Holdings' stock price increased by 2.11% to 3.39 CNY per share, with a total market capitalization of 9.179 billion CNY as of November 14 [1] - The company has seen a year-to-date stock price increase of 42.44%, with a 4.31% rise in the last five trading days and a 21.07% increase over the last 20 days [1] - Nanshan Holdings has appeared on the stock market's "Dragon and Tiger List" twice this year, with the most recent instance on July 4, where it recorded a net buy of -26.2096 million CNY [1] Group 2 - Nanshan Holdings, established on April 30, 2001, and listed on December 3, 2009, operates in various sectors including real estate, integrated housing, ship cabin outfitting, tower crane leasing, oil logistics, and logistics park development [2] - The company's revenue composition includes 58.87% from real estate, 20.54% from manufacturing, 15.83% from warehousing and logistics, 3.58% from integrated urban development, and 1.19% from other businesses [2] - As of October 31, the number of shareholders increased by 10.48% to 55,400, while the average number of circulating shares per person decreased by 9.48% to 24,162 shares [2] Group 3 - Nanshan Holdings has distributed a total of 1.502 billion CNY in dividends since its A-share listing, with 100 million CNY distributed in the last three years [3] - As of September 30, 2025, the top ten circulating shareholders include Hong Kong Central Clearing Limited and various ETFs, with some holdings increasing while others decreased [3]

Core Viewpoint - Chongqing Construction's stock has shown significant fluctuations, with a year-to-date increase of 29.90% but a recent decline of 1.51% over the last five trading days [1] Group 1: Stock Performance - As of November 14, Chongqing Construction's stock price reached 3.91 CNY per share, with a market capitalization of 7.436 billion CNY [1] - The stock has experienced a net inflow of 2.2951 million CNY from major funds, with large orders accounting for 10.17% of total buying and 9.56% of total selling [1] - The stock has appeared on the daily trading leaderboard six times this year, with the latest instance on November 10, showing a net purchase of 25.7701 million CNY [1] Group 2: Company Overview - Chongqing Construction Group was established on April 21, 1998, and went public on February 21, 2017, focusing on housing construction, infrastructure development, and related services [2] - The company's revenue composition includes housing construction (49.32%), infrastructure engineering (36.70%), specialized engineering (6.69%), and other income sources [2] - As of October 31, the number of shareholders decreased by 0.63% to 47,500, with an average of 40,000 circulating shares per shareholder [2] Group 3: Financial Performance - For the period from January to September 2025, Chongqing Construction reported a revenue of 18.418 billion CNY, a year-on-year decrease of 8.58%, and a net profit attributable to shareholders of -625 million CNY, reflecting a significant decline of 1088.34% [2] - The company has distributed a total of 600 million CNY in dividends since its A-share listing, with 64.6608 million CNY distributed over the past three years [3] - As of September 30, 2025, Hong Kong Central Clearing Limited was the seventh-largest circulating shareholder, increasing its holdings by 1.6774 million shares [3]

Core Viewpoint - Lutai A's stock price has shown significant growth this year, with a year-to-date increase of 21.36% and a recent surge of 5.79% over the last five trading days, indicating strong market interest and performance [2]. Company Overview - Lutai Textile Co., Ltd. is located in Zibo City, Shandong Province, and was established on October 18, 1988, with its stock listed on December 25, 2000. The company specializes in the production and sale of various textile products, including cotton-polyester yarn, dyed fabrics, shirts, clothing accessories, and health underwear [2]. - The main revenue composition of Lutai A includes fabric products (65.46%), shirt products (27.31%), electricity and gas (4.92%), and other products (2.32%) [2]. - As of September 30, 2025, the number of shareholders for Lutai A was 46,000, a decrease of 2.93% from the previous period, with an average of 0 circulating shares per person [2]. Financial Performance - For the period from January to September 2025, Lutai A reported a revenue of 4.3 billion yuan, reflecting a year-on-year decrease of 2.3%. However, the net profit attributable to shareholders increased by 74.63% to 503 million yuan [2]. - The company has distributed a total of 5.551 billion yuan in dividends since its listing, with 479 million yuan distributed over the past three years [3]. Market Activity - On November 14, Lutai A's stock price rose by 2.13%, reaching 7.67 yuan per share, with a trading volume of 50.76 million yuan and a turnover rate of 1.14%, resulting in a total market capitalization of 6.269 billion yuan [1]. - In terms of capital flow, there was a net outflow of 1.0538 million yuan from major funds, with significant buying activity from large orders amounting to 9.4568 million yuan, while selling from large orders reached 11.6924 million yuan [1].

Core Viewpoint - Nanjing Xinbai's stock price has shown significant volatility, with a year-to-date increase of 28.96% and a recent decline of 2.00% on November 14, 2023, indicating potential market fluctuations and investor sentiment shifts [1][2]. Financial Performance - For the period from January to September 2025, Nanjing Xinbai reported a revenue of 4.773 billion yuan, a year-on-year decrease of 2.02%, and a net profit attributable to shareholders of 212 million yuan, down 4.14% compared to the previous year [3]. - The company has cumulatively distributed 1.117 billion yuan in dividends since its A-share listing, with 88.3827 million yuan distributed over the last three years [4]. Shareholder and Market Activity - As of September 30, 2025, the number of shareholders increased by 13.85% to 45,700, while the average circulating shares per person decreased by 12.17% to 25,485 shares [3]. - Nanjing Xinbai has appeared on the "Dragon and Tiger List" twice this year, with the most recent instance on July 24, 2023, where it recorded a net buy of -17.0404 million yuan [2]. Business Overview - Nanjing Xinbai, established on May 14, 1991, and listed on October 18, 1993, operates in various sectors including retail, healthcare, and elder care services. Its main revenue sources are health and elder care (36.97%), pharmaceutical manufacturing (23.74%), and medical services (15.26%) [2]. - The company is categorized under the comprehensive industry sector and is associated with concepts such as stem cells, gene sequencing, private hospitals, new retail, and undervalued stocks [2].

Core Viewpoint - Lu'an Environmental Energy has shown fluctuations in stock performance, with a year-to-date increase of 9.18% but a recent decline over the past five trading days and twenty days [1][2]. Group 1: Stock Performance - As of November 13, Lu'an Environmental Energy's stock price increased by 2.15%, reaching 15.23 CNY per share, with a trading volume of 320 million CNY and a turnover rate of 0.71%, resulting in a total market capitalization of 45.559 billion CNY [1]. - The stock has experienced a year-to-date increase of 9.18%, a decline of 3.73% over the last five trading days, and a decrease of 4.39% over the last twenty days [1]. Group 2: Financial Performance - For the period from January to September 2025, Lu'an Environmental Energy reported a revenue of 21.1 billion CNY, a year-on-year decrease of 20.82%, and a net profit attributable to shareholders of 1.554 billion CNY, down 44.45% year-on-year [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Lu'an Environmental Energy was 73,200, a decrease of 9.60% from the previous period, with an average of 40,855 circulating shares per shareholder, an increase of 10.63% [2]. - The company has distributed a total of 25.851 billion CNY in dividends since its A-share listing, with 14.505 billion CNY distributed over the last three years [3]. - The top ten circulating shareholders include new entrants such as Guotai CSI Coal ETF and others, indicating changes in institutional holdings [3].

Core Viewpoint - Shenzhen Expressway's stock price has declined by 23.69% this year, with a recent drop of 2.04% in intraday trading, reflecting ongoing challenges in the market [1][2]. Company Overview - Shenzhen Expressway, established on December 30, 1996, and listed on December 25, 2001, primarily engages in the investment, construction, and management of toll roads [2]. - The company's revenue sources include toll fees (62.51%), construction services under franchise agreements (11.76%), kitchen waste treatment operations (9.33%), wind power generation (7.37%), and other services [2]. Financial Performance - For the period from January to September 2025, Shenzhen Expressway reported a revenue of 6.05 billion yuan, representing a year-on-year growth of 3.24%, and a net profit attributable to shareholders of 1.47 billion yuan, up 7.01% year-on-year [3]. - The company has distributed a total of 14.54 billion yuan in dividends since its A-share listing, with 2.83 billion yuan distributed over the past three years [4]. Shareholder Information - As of September 30, 2025, the number of shareholders increased to 20,800, with an average of 83,524 circulating shares per shareholder, reflecting increases of 5.16% and 14.17% respectively [3]. - Among the top ten circulating shareholders, Huatai-PB SSE Dividend ETF holds 34.63 million shares, an increase of 1.93 million shares from the previous period [4].

Core Viewpoint - Black Peony's stock price has shown significant growth this year, with a year-to-date increase of 106.17%, indicating strong market performance and investor interest [1][2]. Group 1: Stock Performance - As of November 13, Black Peony's stock price rose by 2.09% to 9.75 CNY per share, with a total market capitalization of 10.062 billion CNY [1]. - The stock has experienced a 24.68% increase over the past 20 days and a 54.27% increase over the past 60 days [1]. - The trading volume on November 13 was 36.9967 million CNY, with a turnover rate of 0.37% [1]. Group 2: Financial Performance - For the period from January to September 2025, Black Peony reported a revenue of 2.443 billion CNY, reflecting a year-on-year growth of 34.79% [2]. - The net profit attributable to shareholders was 63.7921 million CNY, which represents a year-on-year decrease of 19.62% [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 13.97% to 27,800 [2]. - The average number of circulating shares per shareholder increased by 16.24% to 37,136 shares [2]. - The company has distributed a total of 2.720 billion CNY in dividends since its A-share listing, with 391 million CNY distributed over the past three years [3]. Group 4: Business Overview - Black Peony is primarily engaged in urbanization construction, textile and apparel, and industrial investment, with revenue contributions of 46.67% from engineering, 27.94% from real estate, and 20.86% from textiles [1]. - The company is classified under the real estate development sector, focusing on residential development [1].

Core Viewpoint - Huabei Mining's stock has experienced a decline in recent trading sessions, reflecting broader challenges in the coal mining sector and a significant drop in revenue and profit for the year [1][2]. Financial Performance - As of October 31, Huabei Mining reported a revenue of 31.92 billion yuan for the first nine months of 2025, a year-on-year decrease of 43.78% [2]. - The net profit attributable to shareholders for the same period was 1.07 billion yuan, down 74.14% year-on-year [2]. - The company's stock price has decreased by 1.05% year-to-date, with a 3.44% drop over the last five trading days [1]. Shareholder Information - The number of shareholders as of October 31 is 36,300, a decrease of 8.06% from the previous period [2]. - The average number of circulating shares per shareholder has increased by 8.77% to 74,127 shares [2]. Dividend Distribution - Since its A-share listing, Huabei Mining has distributed a total of 13.156 billion yuan in dividends, with 7.318 billion yuan distributed over the last three years [3]. Major Shareholders - As of September 30, 2025, the second-largest circulating shareholder is Guotai Zhongzheng Coal ETF, holding 42.6809 million shares as a new shareholder [3]. - Hong Kong Central Clearing Limited is the fourth-largest shareholder, with an increase of 2.1386 million shares [3].

Core Viewpoint - Mingde Biological's stock has shown a mixed performance in recent trading sessions, with a year-to-date increase of 14.50% and a notable decline of 8.77% over the past 60 days [1] Financial Performance - For the period from January to September 2025, Mingde Biological reported revenue of 227 million yuan, reflecting a year-on-year growth of 0.53%. However, the net profit attributable to shareholders decreased significantly by 83.30% to 13.52 million yuan [2] - Cumulatively, since its A-share listing, Mingde Biological has distributed a total of 1.76 billion yuan in dividends, with 875 million yuan distributed over the past three years [3] Shareholder Structure - As of October 31, 2025, the number of shareholders for Mingde Biological decreased by 2.27% to 23,100, while the average number of circulating shares per person increased by 2.32% to 6,763 shares [2] - The top ten circulating shareholders include notable funds such as GF Value Core Mixed A and Rongtong China Wind 1, with some new entrants and changes in holdings among the top shareholders [3] Market Activity - On November 12, Mingde Biological's stock price rose by 2.01% to 19.77 yuan per share, with a trading volume of 39.1 million yuan and a turnover rate of 1.28% [1] - The stock experienced a net outflow of 204,300 yuan from major funds, while large orders showed mixed buying and selling activity [1] Business Overview - Mingde Biological, established on January 28, 2008, specializes in the research, production, sales, and service of in vitro diagnostic reagents and instruments, with a revenue composition of 65.04% from in vitro diagnostic products, 21.91% from third-party medical testing, and 13.05% from agency and other businesses [1] - The company operates within the pharmaceutical and biological industry, specifically in the medical device and in vitro diagnostic sectors [1]